Oxford Immunotec Global PLC
Healthcare · In Vitro & In Vivo Diagnostic Substances · X0 · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annual| FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | |
|---|---|---|---|---|---|---|
| Revenue | $73.7M | $59.8M | $54.7M | $47.0M | $62.8M | $49.5M |
| Operating income | −$6.1M | −$20.7M | −$53.9M | −$25.2M | −$24.2M | −$21.9M |
| Net income | −$1.8M | $120.8M | −$32.9M | −$22.3M | −$24.5M | −$22.2M |
| Total assets | $235.3M | $232.1M | $144.2M | $124.0M | $109.9M | $73.8M |
| Total liabilities | $21.6M | $18.1M | $56.6M | $51.0M | $17.2M | $13.2M |
| Equity | $213.7M | $214.0M | $87.6M | $73.0M | $92.7M | $60.6M |
| EPS (diluted) | $-0.07 | $4.58 | $-1.38 | $-1.00 | — | — |
| Shares out. | 26.6M | 25.9M | 22.7M | 22.6M | 22.5M | 17.6M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2019- Operating margin
- −8.3%
- Net margin
- −2.5%
- Return on equity
- −0.8%
- Return on assets
- −0.8%
- Return on capital (ROCE)
- −2.8%
- Liabilities / assets
- 9.2%
- Debt / equity
- 0.10×
- Book value / share
- $8.03
- Revenue growth (YoY)
- 23.4%
- Net income growth (YoY)
- −101.5%
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2019- Altman Z″ (distress)
- 14.70safe
- Accruals / assets
- 2.3%clean
- Beneish M-Score
- -1.80normal
- Piotroski F-Score
- 3/9weak
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast. What these scores mean →
Signs
● 1 severe● 3 warning● 4 good- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Operating losses (negative operating margin)
- Reported a net loss
- Negative operating cash flow
- Revenue is growing year-over-year
- Conservative leverage (liabilities < 50% of assets)
- Clean earnings (low accruals)
- Altman Z″ in the safe zone
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Kmissed a reporting deadline ↗Mar 18, 2019
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
Material events
SEC Form 8-K · most recent- Completed an acquisition or disposition · Delisting / listing-standard notice · Modified shareholder rights · Change in control · Director / officer change · Amended charter or bylawsMar 8, 2021
- Modified shareholder rights · Shareholder vote · Other material eventFeb 26, 2021
- Entered a material agreement · Other material eventJan 7, 2021
- Other material eventNov 30, 2020
- Results of operationsNov 3, 2020
- Results of operationsAug 4, 2020
- Shareholder voteJun 25, 2020
- Results of operationsMay 5, 2020
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.